Madrigal Pharmaceuticals (MDGL) PT Lowered to $92 at Jefferies, Remains Positive Following MAESTRO-NASH Deep Dive
Tweet Send to a Friend
Jefferies analyst Akash Tewari lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $92.00 (from $151.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
